iCoreConnect (ICCT) Stock Price, News & Analysis

Company Overview

iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCoreClaims, for processing and managing claims submitted by policyholders or dental care providers; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida.

Key Stats

• Today's Range: $2.01 to $2.12
• 50-Day Range: $2.01 to $3.50
• 52-Week Range: $2.01 to $35.80
• Volume: 33,383 shs
• Average Volume: 337,954 shs
• Market Capitalization: $4.24 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ICCT Stock Analysis - Frequently Asked Questions

How have ICCT shares performed this year?

iCoreConnect's stock was trading at $2.50 at the start of the year. Since then, ICCT stock has decreased by 18.0% and is now trading at $2.05.
View the best growth stocks for 2025 here.

When did iCoreConnect's stock split?

iCoreConnect's stock reverse split on the morning of Monday, December 23rd 2024. The 1-20 reverse split was announced on Thursday, December 19th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, December 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Who are iCoreConnect's major shareholders?

iCoreConnect's top institutional shareholders include Magnus Financial Group LLC (2.05%) and Virtu Financial LLC (1.04%).
View institutional ownership trends.

How do I buy shares of iCoreConnect?

Shares of ICCT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of iCoreConnect own?

Based on aggregate information from My MarketBeat watchlists, some other companies that iCoreConnect investors own include Tilray (TLRY), Recursion Pharmaceuticals (RXRX), Editas Medicine (EDIT), Pacific Biosciences of California (PACB), Akanda (AKAN), SoundHound AI (SOUN) and Aridis Pharmaceuticals (ARDS).

Company Calendar

• Today: 2/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: Prepackaged software
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:ICCT
• CUSIP: N/A
• CIK: 1906133
• Web: www.icoreconnect.com
• Phone: 888-810-7706
• Fax: N/A
• Employees: 41
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($63.20)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-15,550,000.00
• Net Margins: -263.12%
• Pretax Margin: -262.63%
• Return on Equity: -1,451.73%
• Return on Assets: -171.32%

Debt

• Debt-to-Equity Ratio: 7.93
• Current Ratio: 0.11
• Quick Ratio: 0.11

Sales & Book Value

• Annual Sales: $8.15 million
• Price / Sales: 0.52
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $9.93 per share
• Price / Book: 0.21

Miscellaneous

• Outstanding Shares: 2,070,000
• Free Float: 841,000
• Market Cap: $4.24 million
• Optionable: Not Optionable
• Beta: 0.87